PETS Stock Analysis: Buy, Sell, or Hold?
PETS - PetMed Express, Inc.
$2.23
-0.02 (-0.89%)
▼
5d:
-2.19%
30d:
-4.7%
90d:
-29.87%
BUY
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Smart Money Accumulation
PETS is down 6.3% this week, but smart money is accumulating calls. Top strike: $2.5 2026-06-18 with 1,654 OI. Call ratio: 100% View Scanner →
Strength: 8.2/10
Get Alerted When PETS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PETS shows positive signals but monitor for confirmation. Market pricing in 49.4% decline. Moderate conviction.
💡 BUY OPPORTUNITY: PETS shows positive signals but monitor for confirmation. Market pricing in 49.4% decline. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: PETS is currently trading at $2.23, which is considered oversold relative to its 30-day fair value range of $2.25 to $2.33. From a valuation perspective, the stock is trading at a discount (Forward PE: 31.9) compared to its historical average (246.5). Remarkably, the market is currently pricing in an annual earnings decline of 49.4% over the next few years. This pessimistic expectation contrasts with the company's recent 266.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PETS is in a strong downtrend. The price is currently testing key support at $2.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PETS is in a strong downtrend. The price is currently testing key support at $2.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.25 -
$2.33
Company Quality Score
61/100
(BUY)
Options IV Signal
45th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
73.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 45th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($2.15)
Trading Range Analysis
30-Day Trading Range
$2.25 -
$2.33
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$0.27
(12.1%)
Support & Resistance Levels
Support Level
$2.22
Resistance Level
$2.43
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
31.86
Wall Street Target
$2.15
(-3.6%)
Revenue Growth (YoY)
-21.7%
Earnings Growth (YoY)
266.7%
Profit Margin
-34.7%
Valuation Discount vs History
-49.4% cheaper
PE vs Historical
31.9 vs 246.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-49.4%
(market-implied from PE analysis)
1-Year Target
$2.01
(-10%)
2-Year Target
$1.81
(-19%)
3-Year Target
$1.63
(-27%)
3-Yr Target (if PE normalizes)
(PE: 32→247)
$12.58
(+464%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 31.9 to 246.5
Stabilization Target:
$17.26
(+673.8%)
PE Expansion Potential:
+673.8%
Share & Embed Analysis
Last updated: May 18, 2026 8:19 AM ET
Data refreshes hourly during market hours. Next update: 9:19 AM
Data refreshes hourly during market hours. Next update: 9:19 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PETS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Pharmaceutical Retailers Stocks
Top-rated stocks in Pharmaceutical Retailers by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HITI
High Tide Inc |
STRONG BUY
5 analysts |
$6 | 59 HOLD |
